Skip to contentB
Biolargo, Inc.
B
BLGOBiolargo, Inc. Q2 2020 · 10-Q
Revenue$418.00K$418.00K−1.9% vs Q2 2019 Net Income-$2.70M-$2.70MN/M vs Q2 2019 EPS Diluted-$0.01-$0.01N/M vs Q2 2019 Gross Profit$217,000+9.6% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Biolargo, Inc. · CIK 880242 · Engraved from SEC EDGAR
Operating Cash Flowderived-$1,294,000N/M Margins · derivedGross margin51.9%+5.4 pt vs Q2 2019
Operating margin-479.7%−130.6 pt vs Q2 2019
Net margin-645.9%−179.5 pt vs Q2 2019
ended Jun 30, 2020 · filed Aug 14, 2020 · 45 d after period end